Impact of Frailty on Postoperative Complications in Oncosurgery
Frailty
To Study the Impact of Frailty on Postoperative Complications in Oncosurgeries
1 other identifier
observational
80
1 country
2
Brief Summary
Advanced ageing is accompanied by loss of reserve in multiple organ systems leading to increased risk of complications after surgery.Frailty is a functional syndrome involving reduced physiological reserve and 25-56% of all elderly surgical patients are reported to be frail .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 28, 2023
CompletedFirst Posted
Study publicly available on registry
February 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2023
CompletedJuly 14, 2023
July 1, 2023
1.3 years
January 28, 2023
July 13, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
To study incidence of postoperative complications in frail patients
Postoperative major complications as myocardial infarction, Respiratory failure, cerebrovascular event, renal failure , re-exploration will be noted and statistically analysed.
upto 7 days
Secondary Outcomes (1)
Length of ICU stay
upto 240 hours.
Study Arms (3)
Non Frail Group
The patients in no frail group did not have any component of Frailty criteria
Pre Frail Group
The patients in prefrail Group had 1-2 component of Frailty criteria.
Frail Group
The patients in Frail Group had 3-5 component of Frailty criteria.
Eligibility Criteria
Patients 65 years old and above undergoing elective major onco- surgeries .
You may qualify if:
- Patients undergoing major onco-surgey
You may not qualify if:
- Patient refusal to participate
- Age \<65 years.
- Emergency surgery
- Pre-existing dementia
- Language barrier
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Rajiv Gandhi Cancer Institute and Research Centre
New Delhi, National Capital Territory of Delhi, 110085, India
Rajiv Gandhi Cancer Institute
Delhi, 110085, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anita Kulkarni, MD
Rajiv Gandhi Cancer Institute and Research Centre , Delhi , India
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 28, 2023
First Posted
February 10, 2023
Study Start
March 1, 2022
Primary Completion
June 30, 2023
Study Completion
July 12, 2023
Last Updated
July 14, 2023
Record last verified: 2023-07